In response to CCl4 injections (research hepatotoxin), Eclipta Alba is able to exert hepatoprotective effects that appear to be related to the Wedelolactone, Desmethylwedelolactone, and flavonoid content.[32] The ethyl acetate fraction (concentrated Wedelolactone) on reducing damage to hepatocytes by CCL4 or alcohol in vitro appears to be statistically significant at 0.1mg/mL, and at 1mg/mL is more hepatoprotective than Silybin (component of Milk Thistle) and in response to phalloidin (hepatotoxin from death cap mushroom) complete protection is noted at 31ug/mL with 50% cytoprotection at 8ug/mL.[3] Desmethylwedelolactone is comparatively potent, although Wedelolactone in response to CCL4 toxicity was the only compound to have significantly protective effects at 0.01mg/mL.[3]
This protective effect has been noted in a living model, where rats injected with CCL4 had a 77.7% mortality rate was reduced to 22.2% after ingesting 6.6mL/kg leaf extract (since 180mL was made from 250g leaves, this is about 9.2g/kg) three times prior to insult (48, 24, an 4 hours prior to injections).[33] ALP, AST, and ALT were reduced by 55%, 42%, and 59% respectively and there appeared to be markedly less damage when histology was observed.[33] Another study injecting CCL4 into rats who merely consumed 500mg/kg of the 1:1 water:ethanolic extract daily for 15 days prior to the toxin significantly reduced the CCL4 induced increase in alkaline phosphatase and amidopyrine N-demethylase, the former to near baseline levels, with some preservation of G6P activity.[34]
Hepatoprotective effects are possibly synergistic either or both Phyllanthus fraternus and Curcumin,[35] and are comparatively greater than both Tephrosia purpurea and boerhaavia diffusa.[36]
Has protective effects against the liver (in vitro) in response to toxins, with preliminary evidence suggesting greater potency that Milk Thistle
Echinocystic acid and its glycosides, mostly Eclalbasaponin II, appear to reduce hepatic stellate cell proliferation in a dose and time dependent manner, with Eclalbasaponin II being as potent as 18β-Glycyrrhetinic acid at 100uM.[15]
Appears to have some anti-fibrotic effects
The RNA dependent RNA polymerase (RdRp) activity of HCV replicase (NS5B) appears to be inhibited by a water extract of Eclipta Alba with an IC50 value of 11μg/mL; this was confirmed in cell cultures where 130μg/mL inhibited 95% of replication over 48 hours of observation.[1] This concentration-dependent inhibition of hepatitis replication appeared to be due to Wedelolactone (IC50 7.7μM) where 10μM inhibited more than 80% of NS5B expression and 50μM abolished expression, while replication was inhibited 30% and 80% respectively; Luteolin and Apigenin also shared this activity, but were significantly weaker (IC50s above 50μM) although combining Wedelolactone with luteolin in a 1:1 ratio reduced the IC50 to 4.5μM and pairing Luteolin with Apigenin resulted in synergism (IC50 24.6μM).[1]
Appears to have potential to inhibit hepatitis viral replication, with the main bioactive (Wedelolactone) being synergistic with other components of Eclipta Alba (Luteolin)